Cost-Effectiveness Analysis And Budget Impact Of Concor® Am Versus Bisoprolol Plus Amlodipine In Systemic Arterial Hypertension Treatment, From The Perspective Of The Brazilian Public Health System

May 1, 2015, 00:00 AM
10.1016/j.jval.2015.03.801
https://www.valueinhealthjournal.com/article/S1098-3015(15)00858-X/fulltext
Section Title : Cardiovascular Disorders
Section Order : 237
First Page : A138
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(15)00858-X&doi=10.1016/j.jval.2015.03.801
HEOR Topics :
Tags :
Regions :